Filter
363
Filtered Results: 363
Text search:
National
Pharmacovigilance
Policy
Featured
Recommendations
41
New Publications
130
Language
Document type
No document type
207
Guidelines
56
Studies & Reports
45
Strategic & Response Plan
20
Manuals
18
Fact sheets
7
Training Material
5
Situation Updates
4
Infographics
1
Countries / Regions
Kenya
21
Nigeria
15
Ghana
14
Uganda
14
India
14
Western and Central Europe
13
Rwanda
11
Global
11
Eastern Europe
11
Nepal
10
South Africa
10
Namibia
9
Ethiopia
8
Sierra Leone
7
Malawi
7
Tanzania
6
Philippines
5
Congo, Democratic Republic of
5
South–East Asia Region
5
Liberia
5
Africa
4
Cambodia
4
West and Central Africa
4
Bangladesh
4
Russia
4
Zambia
4
Lesotho
3
Benin
3
Senegal
3
Zimbabwe
3
Mozambique
3
Latin America and the Carribbean
3
East and Southern Africa
3
Botswana
3
Ukraine
2
Syria
2
Haiti
2
Asia
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Sudan
2
Libya
2
Indonesia
2
Myanmar / Burma
2
Madagascar
2
Eswatini/ Swaziland
2
Pakistan
2
Thailand
1
Gambia
1
Cameroon
1
Laos
1
Burkina Faso
1
Afghanistan
1
Guinea
1
Jordan
1
Western Pacific Region
1
Maldives
1
Lebanon
1
Sri Lanka
1
Yemen
1
Georgia
1
Mali
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Drugs & Medical Equipment
65
Policies
58
Policies & Guidelines HIV & TB
37
Guidelines
34
Studies & Reports
18
Women & Child Health
10
TB
10
NTDs & Others
8
Malaria
8
Statistics
6
Pharmacy & Technology
5
COVID-19
4
Countries
4
Non-communicable Diseases
4
HIV & STI
4
Disease Prevention & Control
4
Communicable Diseases
3
Hepatitis
3
Vaccine-preventable Diseases
3
Community Health
3
Capacity Building
3
Taeniasis/ Cysticercosis
2
Snakebites
2
Pharmaceutical Assessments
2
NCD
2
Medical Devices & Equipment
2
Immunization
2
General Guidelines
2
Leprosy
2
Paediatrics
1
Clinical Training
1
Rabies
1
Helminthiasis
1
Under-5 nutrition
1
Disaster Preparedness
1
Trachoma
1
Onchocerciasis
1
Schistosomiasis
1
Dermatology
1
Lymphaticfilariasis
1
Cancer
1
Vector Control
1
Community Health
1
Pediatric cancer
1
Non-communicable Diseases NCD
1
Public Health
1
Pediatrics
1
Cardiovascular Diseases
1
Clinical Guidelines
1
Demograhic Health Surveys DHS
1
Other
1
Respiratory Infections
1
Communicable Diseases
1
Health Systems
1
Maternal Health
1
Primary Health Care
1
Dengue
1
Leishmaniasis
1
Laboratory Quality Assurance
1
Key Resources
1
Global Health
1
Pharmacy & Technologies
1
Toolboxes
Country specific
15
Rational use of Medicine
11
Drug resistant TB
11
Access & Strategy
8
Pharmacovigilance
8
Reports & Studies
7
Essential Medicines
6
Falsified & Substandard
5
Traditional & Herbal Medicines
5
Antiretroviral Treatment ART
5
Clinical Aspects, Treatment & Prevention
4
Clinical Guidelines
4
Supporting tools
4
Country Specific
4
Immunization Guidelines
4
Eastern Europe & Central Asia
4
SEAR (South-east Asia Region)
4
Adults
3
Hospital Readiness/Essential Health Services
3
Inactivated COVID-19 Vaccines
3
Essential Medicines & Devices Lists
3
General Guidelines for Rational Use
3
Overview, Studies & Reports
3
Research & Access
3
Western & Central Europe
3
Treatment & Prevention
2
Preparedness, Response & Risk Communication
2
Prevention & Control
2
Children & Adolescents
2
WPRO (Western Pacific Region)
2
Children
2
Georgia
2
Drug resistance
2
Ethiopia
2
International
2
Prevention & Preparedness
2
Studies
2
General
2
Oxygen Therapy
2
Logistics & Supply
2
Prices and Patents
2
Pharmaceutical Assessments
2
Pharmacy Practice
2
One Health
2
Waste Managment
2
Studies & Reports
2
Education of students & professionals
2
Uganda
2
HIV service delivery
2
Reports & Studies
2
Eastern Europe and central Asia
2
Outbreak Prevention & Control
1
Clinical Guidelines
1
Childhood TB
1
Agriculture & Veterinary
1
Clinical Guidelines
1
Azerbaijan
1
Clinical Aspects
1
Vaccination
1
Ukraine
1
South Africa
1
Influenza
1
Treatment Guidelines HIV
1
Namibia
1
Public Health
1
HIV
1
Prevention & Control
1
Rwanda
1
Research
1
Vaccination
1
TB & Other Vulnerable Populations
1
Country Guidelines
1
Belarus
1
Reports
1
Russia
1
Health Personnel
1
Infection Control General
1
Surveillance & Contact tracing
1
For Pregnant Women
1
Training, others
1
Appeals and Response Plans
1
Gender Aspects
1
Communication Material
1
TB/HIV
1
Fair Allocation & Ethical Aspects
1
COVAX Initiative
1
Biontech/Pfizer Comirnaty
1
Vaxzevria (Astra Zeneca)
1
Johnson & Johnson
1
Standard Operating Procedure (SOP)
1
Midwives
1
Pharmacy Management
1
Quality Assurance
1
Antimicrobial Resistance (AMR)
1
Waste management
1
Leishmaniasis
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Statistics & Facts
1
Studies & Reports
1
Patient Safety
1
Clinical Aspects & Diagnosis
1
Clinical Aspects & Diagnosis
1
Prevention & Strategies
1
Clinical Aspects & Diagnosis
1
Diagnosis
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Romania
1
Asia and Pacific
1
Co-Morbidities (except TB)
1
Neurological Disorders
1
General Aspects
1
Human Rights & the Right to Health
1
TB & Prisoners
1
Training
1
General Public
1
TB/HIV Coinfection
1
Clinical Guidelines
1
Kazakhstan
1
AmR (Region of Americas)
1
TB
1
Reports & Studies Children HIV
1
Kenya
1
Meningitis & Encephalitis
1
Preparedness & Prevention
1
Treatment & Clinical Management
1
International Journal of Infectious Diseases 32 (2015) 111–117
Recommendations for a public health approach
2010 revision
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are...
Dans le cadre du projet Tracmed, une étude sur les outils législatifs et juridiques à disposition des ordres des pharmaciens dans la lutte contre les médicaments falsifiés a été réalisée en juillet 2015. Cette étude porte sur le Bénin, le Burkina Faso, la Guinée et le Mali.
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an...
Interim guidance. 12 May 2021. The Continuity of essential health services: Facility Assessment Tool can be used by countries to rapidly assess the capacity of health facilities to maintain the provision of essential health services during the COVID-19 pandemic. It can help to alert the authorities ...
Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines, equipment and supplies on site and to ident...
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized ...
Smallpox eradication was certified in 1980. Mpox has been endemic in Central and West African countries since it was first detected in 1958 . It is a zoonosis; cases are often found close to tropical rainforests where various animals carry the orthopoxvirus that causes the disease. In endemic countr...
